Date  | Open(₹)  | High(₹)  | Low(₹)  | Close(₹)  | No. Of Trades(₹)  | Total Turnover(₹)  | Deliverable Quantity(₹)  | 
|---|---|---|---|---|---|---|---|
06-Oct-2025  | 1,323  | 1,326 | 1,305 | 1,323.2 | 9,800 | 11,36,81,669.8 | 34,329 | 
07-Oct-2025  | 1,321  | 1,404 | 1,316.1 | 1,359.8 | 39,826 | 98,82,93,381.8 | 2,45,499 | 
08-Oct-2025  | 1,353.1  | 1,361 | 1,345.5 | 1,352.1 | 6,869 | 6,67,48,499.4 | 24,333 | 
09-Oct-2025  | 1,362.6  | 1,368.2 | 1,336.5 | 1,339.5 | 9,886 | 12,40,04,552.6 | 43,748 | 
10-Oct-2025  | 1,349.5  | 1,361.6 | 1,330.6 | 1,334.5 | 9,161 | 12,50,48,213.6 | 42,447 | 
13-Oct-2025  | 1,338.3  | 1,338.3 | 1,320.2 | 1,323.5 | 8,876 | 7,85,37,619.6 | 27,823 | 
14-Oct-2025  | 1,329  | 1,330.9 | 1,302.3 | 1,306.1 | 24,471 | 26,61,17,623.5 | 1,26,199 | 
15-Oct-2025  | 1,315  | 1,317.7 | 1,291.9 | 1,297.3 | 8,487 | 12,54,75,692.5 | 50,220 | 
16-Oct-2025  | 1,304.9  | 1,314.9 | 1,279.2 | 1,288.4 | 18,032 | 18,92,97,591.3 | 82,113 | 
17-Oct-2025  | 1,297  | 1,297 | 1,280 | 1,286.3 | 6,651 | 6,54,27,451.8 | 21,771 | 
20-Oct-2025  | 1,291.5  | 1,291.5 | 1,262 | 1,271 | 17,060 | 13,37,70,562.5 | 51,970 | 
21-Oct-2025  | 1,278.5  | 1,285 | 1,276.3 | 1,281.3 | 1,497 | 1,52,42,187.6 | 5,765 | 
23-Oct-2025  | 1,287.4  | 1,292 | 1,271 | 1,276.8 | 10,885 | 15,72,81,087.1 | 73,021 | 
24-Oct-2025  | 1,279.4  | 1,290 | 1,251.6 | 1,268.7 | 17,727 | 15,63,85,471.3 | 63,552 | 
27-Oct-2025  | 1,278.5  | 1,302.3 | 1,271.9 | 1,298 | 8,760 | 10,95,53,042.4 | 35,735 | 
28-Oct-2025  | 1,305  | 1,308 | 1,280 | 1,285.9 | 9,511 | 8,13,12,641.5 | 38,311 | 
29-Oct-2025  | 1,292.3  | 1,300.1 | 1,280.1 | 1,289.9 | 11,107 | 10,85,88,462.6 | 51,828 | 
30-Oct-2025  | 1,289.9  | 1,295.1 | 1,273.3 | 1,288.9 | 10,948 | 7,59,16,662 | 35,410 | 
31-Oct-2025  | 1,296  | 1,296 | 1,268 | 1,271.2 | 11,113 | 13,59,28,235.2 | 73,557 | 
03-Nov-2025  | 1,271.2  | 1,320 | 1,270 | 1,309.7 | 15,692 | 16,50,40,685.7 | 69,263 | 
This consolidation aims to streamline all of Ipca Group's US generics formulations under a single entity, enhancing operational efficiency.
 IIFL Customer Care Number 
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000  / 7039-050-000
 IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.